Chandra Bhagat Pharma Ltd.

147.50 ▼0%

14 February 2024, 04:09:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cbcpharma.com
Market Cap 111.29 Cr.
Enterprise Value(EV) 128.83 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.20 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 122.92 Trailing Twelve Months Ending 2023-03
Industry PE 41.82 Trailing Twelve Months Ending 2023-03
Book Value / Share 35.15 Trailing Twelve Months Ending 2023-03
Price to Book Value 4.20 Calculated using Price: 147.50
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.75 Cr. 7,545,056 Shares
FaceValue 10
About Chandra Bhagat Pharma Ltd.
The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market.

Chandra Bhagat Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Chandra Bhagat Pharma Ltd. Performance

1 Day
1 Week
+7.16%
1 Month
+7.08%
3 Month
+45.68%
6 Month
+9.26%
1 Year
+40.48%
2 Year
+18.28%
5 Year
10 Year

Chandra Bhagat Pharma Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 6.89 5.38 9.33 13.44 6.46 1.67 0.78 3.19 3.49
Return on Capital Employed (%) 10.4 12.62 14.34 17.58 13.4 7.16 7.63 8.83 7.3
Return on Assets (%) 1.16 0.82 1.32 1.82 0.98 0.4 0.26 1.1 1.36

Chandra Bhagat Pharma Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 7 7 8 14 26 26 27 27 28
Non Curr. Liab. 0 0 11 21 16 15 13 8 6 6
Curr. Liab. 36 38 37 29 53 34 33 38 27 25
Minority Int.
Equity & Liab. 42 44 56 58 83 75 72 72 61 60
Non Curr. Assets 1 1 1 1 0 0 0 0 1 3
Curr. Assets 41 44 55 57 81 73 70 71 59 56
Misc. Exp. not W/O 0 1 1 1 1 1
Total Assets 42 44 56 58 83 75 72 72 61 60

Chandra Bhagat Pharma Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 48 61 80 90 97 106 94 71 94 120
Other Income 1 0 0 0 1 0 0 0 2 0
Total Income 49 61 80 90 98 107 94 71 96 120
Total Expenditure -46 -58 -76 -85 -92 -102 -91 -67 -91 -116
PBIDT 2 3 5 5 5 5 4 4 4 3
Interest -2 -2 -4 -4 -4 -4 -3 -4 -3 -2
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 -1 0 0 0 0 0
Exceptional Items
PAT 0 0 0 1 1 1 0 0 1 1
Adjusted EPS 8 10 8 2 3 1 0 0 1 1

Chandra Bhagat Pharma Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -9 -6 4 -7 8 12 5
Cash Fr. Inv. 0 0 0 0 0 0 0
Cash Fr. Finan. 8 7 -4 7 -6 -10 -4
Net Change -1 0 0 0 2 3 1
Cash & Cash Eqvt 1 1 0 0 3 6 6

Chandra Bhagat Pharma Ltd. Shareholding Pattern

8 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%) 2023-09 (%)
Promoter 70.42 70.42 71.80 71.80 70.11 69.09 68.24 68.69
Public 29.58 29.58 28.20 28.20 29.89 30.91 31.76 31.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Chandra Bhagat Pharma Ltd. Announcements

Thu, 09 Nov 2023
Board Meeting Outcome for Results For The Half Year Ended 30Th September 2023.
Outcome of the board meeting held on 09th September 2023 for approval of un-audited financial result as on 30.09.2023.
Thu, 09 Nov 2023
Financial Result As On 30.09.2023.
Financial Result for half year ended 30th September 2023.
Thu, 02 Nov 2023
Board Meeting Intimation for Approval Of Un-Audited Financial Result For Half Year Ended 30Th September 2023.
Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve un-audited financial result for half year ended 30th September 2023.

Chandra Bhagat Pharma Ltd. Technical Scans

Wed, 14 Feb 2024
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month High Close Crossing Last Month High
Opening at High Opening at High
Opening at Low Opening at Low
Opening at Low for 3 days Opening at Low for 3 days

Chandra Bhagat Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Chandra Bhagat Pharma Ltd. FAQ's

What is Chandra Bhagat Pharm share price?

Can I buy Chandra Bhagat Pharm shares now?

What is the Market Cap of Chandra Bhagat Pharm?

What are the key metrics to analyse Chandra Bhagat Pharm?

What is the 52 Week High and Low of Chandra Bhagat Pharm?